Disruptions in purine metabolism pathways can lead to a range of neurological disorders, as seen in diseases such as Lesch–Nyhan syndrome, which is characterized by HGPRT deficiency. This evidence concerns the gene HPRT1 and Lesch-Nyhan syndrome.